He2 75.jpg

CDC vaccine advisory committee votes to remove Hepatitis B vaccine recommendation at birth: What has changed, and what remains the same

In a big change to the infant vaccination process, the CDC’s (Centers for Disease Control and Prevention) vaccine advisory committee has voted to move away from a “one‑size‑fits‑all” hepatitis B shot at birth, and instead, let parents and clinicians decide on a case‑by‑case basis for babies, whose mothers test negative for hepatitis B. This however,…

Read More
1764299780 unnamed file.jpg

Stocks to buy or sell: Stock recommendation by brokers for November 27, 2025 -check list

JP Morgan, Maquire see 30K nifty level by end-2026JP Morgan has raised the base case for the nifty target to 30,000 points for end-2026. Analysts feel with supportive fiscal and monetary policies, recovering domestic demand and broad-based sectoral growth, corporate earnings are set to rebound. They feel India’s valuations remain at a premium, but the…

Read More
1764039224 untitled design 50.jpg

Buy or sell: Stock recommendation by brokers for November 25, 2025

Emkay Global has downgraded ACC to sell due to weak margin trends and slower capex execution with the target price cut sharply to Rs 1,600 from Rs 2,280. Analysts said that ACC’s valuation revised to 7x EV/EBITDA (economic value/earnings before interest, taxes, depreciation and amortisation from 9x given deteriorating fundamentals. They have cut ACC’s FY27…

Read More
1763610082 untitled design 7.jpg

Buy or sell: Stock recommendation by brokers for November 20, 2025

Morgan Stanley initiated its coverage on LG Electronics with an overweight rating and a target price of Rs 1,864. Analysts said the company stands out across many categories in a highly competitive consumer durables market with industry-leading margins and best-in-class capital efficiencies. They expect revenues and margins to be driven by its new capacity, and…

Read More
1763444217 untitled design 8.jpg

Buy or sell: Stock recommendation by brokers for November 18, 2025

Jefferies has an underperform rating on Tata Motors PV with the target price at Rs 300. Analysts said the company reported earnings before interest, taxes, depreciation, and taxes (EBITDA) loss in the July-Sept quarter (Q2FY26), dragged by cyberattack at JLR. Cyberattack-related disruptions continue in Q3FY26 and should normalize by Q4FY26. Nevertheless, analysts see multiple headwinds…

Read More